ScottsMiracle-Gro Announces Timing of Third Quarter 2024 Financial Results and Webcast
MARYSVILLE, Ohio, July 23, 2024 (GLOBE NEWSWIRE) — The Scotts Miracle-Gro Company (NYSE: SMG), the world’s leading marketer of branded […]
JE Cleantech Holdings Limited Announces Continuation of $1,000,000 Stock Repurchase Program
SINGAPORE, July 23, 2024 (GLOBE NEWSWIRE) — JE Cleantech Holdings Limited (NASDAQ: JCSE) announced today that JCSE is continuing its […]
Altisource Portfolio Solutions S.A. Schedules Second Quarter 2024 Conference Call
LUXEMBOURG, July 23, 2024 (GLOBE NEWSWIRE) — On Thursday, July 25, 2024, Altisource Portfolio Solutions S.A. (“Altisource”) (NASDAQ: ASPS) will […]
INmune Bio Inc. Publishes Novel Biology on Natural Killer Cancer Immunotherapy INKmune™ in the Journal for ImmunoTherapy of Cancer
Publication of detailed analysis on INKmune biology compared to cytokine stimulated cells demonstrates important anti-tumor memory like NK cell characteristics […]
Itron Invites Nominations for 2024 Innovator Award
LIBERTY LAKE, Wash., July 23, 2024 (GLOBE NEWSWIRE) — Itron, Inc. (NASDAQ: ITRI), which is innovating new ways for utilities […]
Fanhua Announces Completion of Share Option Cash Exercises by Key Employees
GUANGZHOU, China, July 23, 2024 (GLOBE NEWSWIRE) — Fanhua Inc. (Nasdaq: FANH) (the “Company” or “Fanhua”), a leading independent technology-driven […]
Reborn Coffee Provides First Quarter 2024 Corporate Update and Financial Results
Q12024 Revenue Increased 35% to $1.5 Million Q1 2024 Gross Profit Increased 51% to $1.1 Million BREA, Calif., July 23, […]
APA Corporation Publishes 2024 Sustainability Report
HOUSTON, July 23, 2024 (GLOBE NEWSWIRE) — APA Corporation (Nasdaq: APA) today published its 2024 Sustainability Report. Highlights from the […]
First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s FDA-Approved QUELIMMUNE Therapeutic Device
DENVER, July 23, 2024 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) reports treatment of the first […]
Adial Pharmaceuticals Advances to Second Cohort in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
GLEN ALLEN, Va., July 23, 2024 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage […]
